Fibromyalgia References

 

[1] Beers M and Berkow R.  Fibromyalgia.  The Merck Manual 17th Ed. 1999: 481-482.
 

[2] Beers M and Berkow R.  Fibromyalgia.  The Merck Manual 17th Ed. 1999: 481-482.
 

[3] www.niams.nih.gov  National Institute of Arthritis and Musculoskeletal and Skin Diseases.  November 2004.
 

[4] Wikner J, Hirsch U, Wetterberg L, Rojdmark S.  Fibromyalgia- a syndrome associated with decreased nocturnal melatonin secretion.  Clin Endocrinol (Oxf). 1998 Aug; 49(2): 179-183.
 

[5] Citera G et al.  The effect of melatonin in patients with fibromyalgia: a pilot study.  Clin Rheumatol.  2000; 19(1): 9-13.
 

[6] Julh JH et al.  Fibromyalgia and serotonin pathway.  Altern Med Rev.  1998 Oct; 3(5): 367-375.
 

[7] Caruso I et al.  Double blind study of 5-HTP versus placebo in the treatment of primary fibromyalgia.  J Int Med Res. 1990 May; 18(3): 201-209.
 

[8] Tavoni A, Vitali C, Bombardieri S, Pasero G.  Evaluation of s-adenosylmethionine in primary fibromyalgia: a double blind crossover study.  Am J Med.  1987 Nov 20; 3(5A): 107-110.
 

[9] Jacobsen S, Danneskiold-Samsue B, Andersen RB.  Oral s-adenosylmethionine in primary fibromyalgia: a double blind clinical evaluation.  Scan J Rheumatol.  1991; 20(4): 294-302.
 

[10] Regland B et al.  Increased concentration of homocysteine in cerebral spinal fluid in patients with fibromyalgia and chronic fatigue syndrome.  Scan J Rheumatol.  1997; 26(4): 301-307.
 

[11] Russell IJ, Michalek JE, Flechas JD, Abraham GE.  Treatment of fibromyalgia syndrome with SuperMalic: a randomized double blind placebo controlled crossover pilot study.  J Rheumatol.  1995 May; 22(5): 953-958.
 

 

Return to Fibromyalgia Introduction